A bioengineered anti-VEGF protein with high affinity and high concentration for intravitreal treatment of wet age-related macular degeneration.

Authors:
Huang C; Wang Y; Huang J; Liu H; Chen Z and 3 more

Journal:
Bioeng Transl Med

Publication Year: 2023

DOI:
10.1002/btm2.10632

PMCID:
PMC10905556

PMID:
38435828

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Bioeng Transl Med

Detailed journal information not available.

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

4/6

66.7% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Evidence found in paper:

"data s1."

Code Sharing

COI Disclosure

Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare that no conflict of interests."

Funding Disclosure

Evidence found in paper:

"The authors acknowledge Tsinghua University ‐ Peking Union Medical College Hospital Collaboration Foundation (Project Number 20191080837) for providing research funding for this project. We also thank Dr. Jie Ma (Quaerite Biopharm Research, Beijing) for her help in HUVEC proliferation and reporter gene assay, western blot analysis."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025